Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis
(2016)
Journal Article
Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., & Cleland, J. G. (2017). Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4(1), 40-45. https://doi.org/10.1002/ehf2.12112
Background Previous studies have shown that xanthine oxidase inhibitors (XOI) might improve outcome for patients with cardiovascular disease. However, more evidence is required. Methods and results We published a meta-analysis of trials conducted bef... Read More about Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis.